FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PN3PSY9

Market Closed - Deutsche Boerse AG 15:50:33 2024-06-21 EDT
8.06 EUR -0.62% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-1.23%
1 month-8.51%
Date Price Change
24-06-21 8.06 -0.62%
24-06-20 8.11 +13.59%
24-06-19 7.14 -5.93%
24-06-18 7.59 -3.80%
24-06-17 7.89 -0.38%

Delayed Quote Deutsche Boerse AG

Last update June 21, 2024 at 03:50 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN3PSY
ISINDE000PN3PSY9
Date issued 2022-06-02
Strike 341.4 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 85.28
Lowest since issue 6.53
Spread 0.25
Spread %3.03%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
342.6 USD
Average target price
372.9 USD
Spread / Average Target
+8.84%
Consensus